Overall survival and durable responses in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib combined with trametinib

Georgina V. Long*, Jeffrey S. Weber, Jeffrey R. Infante, Kevin B. Kim, Adil Daud, Rene Gonzalez, Jeffrey A. Sosman, Omid Hamid, Lynn Schuchter, Jonathan Cebon, Richard F. Kefford, Donald Lawrence, Ragini Kudchadkar, Howard A. Burris, Gerald S. Falchook, Alain Algazi, Karl Lewis, Igor Puzanov, Nageatte Ibrahim, Peng SunElizabeth Cunningham, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, Kiran Patel, Keith T. Flaherty

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

233 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Overall survival and durable responses in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib combined with trametinib'. Together they form a unique fingerprint.

Medicine & Life Sciences